For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The most common symptoms of sleep apnea are daytime sleepiness, loud snoring, and restless sleep. The Europe market for sleep apnea diagnostic and therapeutic market is expected to grow at a CAGR of 6.15% from 2019-2027. Germany, the United Kingdom, France, Italy, Spain and the Rest of Europe are considered for the market analysis.
The rise in disposable income and high awareness about the benefits of sleep aids is expected to further fuel the market growth in this region. Germany is one of the major economies with a strong population in millions, the presence of high-quality healthcare infrastructure, and favorable reimbursement policies. It is one of the major medical tourism destinations in Europe and hence caters to the healthcare needs of other European nations.
The major market players operating in Europe are Koninklijke Philips N.V. (Philips), GE Healthcare, Teleflex, Fisher & Paykel Healthcare, CareFusion (Merged With Becton Dickinson), Invacare Corp., Smiths Group PLC (Smiths Medical), Braebon Medical Corporation, Medtronic PLC, Somnomedics, Itamar Medical Ltd., Nihon Kohden Corporation, Cadwell, Drive Devilbiss Healthcare and Resmed Inc.